Lotus Tissue Repair Scores $26 Million in Series A Round
Rare disease start-up scores Series A financing and technology patents to develop a treatment for a deadly genetic disorder.
Rare disease start-up scores Series A financing and technology patents to develop a treatment for a deadly genetic disorder.